As of Feb 28, 2025
VanEck ETF Trust VanEck Morningstar Wide Moat Value ETF (BATS: MVAL)
Ticker | Name | Share % | |
---|---|---|---|
IFF | International Flavors & Fragrances, Inc | 3.84% | |
RTX | Rtx Corp | 4.91% | |
MO | Altria Group Inc | 4.63% | |
SCHW | Charles Schwab Corp/the | 4.35% | |
BIIB | Biogen Inc | 4.10% | |
PFE | Pfizer Inc | 4.33% | |
CPB | The Campbell'S Company | 3.90% | |
IE | Medtronic Plc | 3.96% | |
MAS | Masco Corp | 3.81% | |
USB | Us Bancorp | 3.75% | |
GILD | Gilead Sciences Inc | 5.88% | |
BMY | Bristol-Myers Squibb Co | 5.13% | |
BA | Boeing Co | 4.71% | |
KVUE | Kenvue Inc | 4.68% | |
AS | Nxp Semiconductors Nv | 4.24% | |
NKE | Nike Inc | 3.91% |
The MVAL ETF is currently trading at $30.31, which represents a -4.09% change. Over the past 52 weeks, the ETF has traded as high as $34.40 and as low as $28.89.
The expense ratio of MVAL is 0.49%. This represents the annual fee that all funds or ETFs charge their shareholders.
The total Assets Under Management (AUM) for MVAL is 4.71M. This represents the total market value of the assets managed by the ETF.
MVAL follows a Large Cap Blend investment style.
The top holdings of MVAL include: IFF (3.84%), RTX (4.91%), MO (4.63%), SCHW (4.35%), BIIB (4.1%). These represent the largest positions in the ETF's portfolio.
Average daily volume data for MVAL is currently not available.